Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × Immunotherapy × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 20 Neoplasm Metastasis 7 Lung Neoplasms 7 Esophageal Neoplasms 7 Melanoma 6 Breast Neoplasms 5 Stomach Neoplasms 4 Neoplasms 4 Uterine Cervical Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Colorectal Neoplasms 3 Carcinoma, Hepatocellular 3 Rectal Neoplasms 2 Pathologic Complete Response 2 Gastrointestinal Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Carcinoma, Renal Cell 2 Carcinoma 2 Breast Neoplasms, Male 2 Unresectable Hepatocellular Carcinoma 1 Turcot syndrome 1 Triple Negative Breast Neoplasms 1 Thymus Neoplasms 1 Thymoma 1 Thymic epithelial tumor 1 Solid Tumor Cancer 1 Small Cell Lung Carcinoma 1 Small Cell Lung Cancer Extensive Stage 1 Sarcoma 1 Radiation Injuries 1

Interventions

Cyclophosphamide 58 Rituximab 47 fludarabine 38 fludarabine phosphate 25 obinutuzumab 17 venetoclax 16 Lenalidomide 16 ibrutinib 15 Etoposide 14 Prednisone 13 pirtobrutinib 12 Whole-Body Irradiation 12 Mycophenolic Acid 11 Melphalan 11 Bendamustine Hydrochloride 11 Tacrolimus 10 Specimen Handling 10 Filgrastim 10 Doxorubicin 10 Biopsy 10 Vincristine 9 Magnetic Resonance Spectroscopy 9 Granulocyte Colony-Stimulating Factor 9 pembrolizumab 8 Stem Cell Transplantation 8 Peripheral Blood Stem Cell Transplantation 8 Nivolumab 8 Gemcitabine 8 Cytarabine 8 tocilizumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡